United Therapeutics Corporation Income Taxes Paid
United Therapeutics Corporation (UTHR) reported Income Taxes Paid of $102.50 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2026-08-05
- United Therapeutics Corporation income taxes paid, net for the quarter ending 2026-06-30 was $101.00M, a 60.14% decline year-over-year.
- United Therapeutics Corporation income taxes paid, net for the quarter ending 2026-03-31 was $1.50M, a 200.00% increase year-over-year.
- United Therapeutics Corporation income taxes paid, net for the quarter ending 2025-12-31 was $51.00M, a 54.18% decline year-over-year.
- United Therapeutics Corporation income taxes paid, net for the quarter ending 2025-09-30 was $8.40M, a 89.13% decline year-over-year.
- United Therapeutics Corporation income taxes paid, net for fiscal 2025 was $313.30M, a 21.79% decline from fiscal 2024.
- United Therapeutics Corporation income taxes paid, net for fiscal 2024 was $400.60M, a 20.48% increase from fiscal 2023.
- United Therapeutics Corporation income taxes paid, net for fiscal 2023 was $332.50M, a 20.60% increase from fiscal 2022.
- United Therapeutics Corporation income taxes paid, net for fiscal 2022 was $275.70M, a 79.84% increase from fiscal 2021.
| Period end | Income Taxes Paid, Net 3 month | Income Taxes Paid, Net 3 month as first filed | Income Taxes Paid, Net 6 month | Income Taxes Paid, Net 6 month as first filed | Income Taxes Paid, Net 9 month | Income Taxes Paid, Net 9 month as first filed | Income Taxes Paid, Net 12 month | Income Taxes Paid, Net 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $101.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $102.50M 10-Q · filed 2026-08-05 | $153.50M derived: sum of 3 quarters · filed 2026-08-05 | $161.90M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | $1.50M 10-Q · filed 2026-05-06 | $52.50M derived: sum of 2 quarters · filed 2026-05-06 | $60.90M derived: sum of 3 quarters · filed 2026-05-06 | $314.30M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | $51.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $59.40M derived: sum of 2 quarters · filed 2026-02-25 | $312.80M derived: sum of 3 quarters · filed 2026-08-05 | $313.30M 10-K · filed 2026-02-25 | ||||
| 2025-09-30 | $8.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $261.80M derived: sum of 2 quarters · filed 2026-08-05 | $262.30M 10-Q · filed 2025-10-29 | $373.60M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | $253.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $253.90M 10-Q · filed 2026-08-05 | $365.20M derived: sum of 3 quarters · filed 2026-08-05 | $442.50M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-31 | $500.00K 10-Q · filed 2026-05-06 | $111.80M derived: sum of 2 quarters · filed 2026-05-06 | $189.10M derived: sum of 3 quarters · filed 2026-05-06 | $396.40M derived: sum of 4 quarters · filed 2026-05-06 | ||||
| 2024-12-31 | $111.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $188.60M derived: sum of 2 quarters · filed 2026-02-25 | $395.90M derived: sum of 3 quarters · filed 2026-02-25 | $400.60M 10-K · filed 2026-02-25 | ||||
| 2024-09-30 | $77.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $284.60M derived: sum of 2 quarters · filed 2025-10-29 | $289.30M 10-Q · filed 2025-10-29 | $385.90M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-06-30 | $207.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $212.00M 10-Q · filed 2025-07-30 | $308.60M derived: sum of 3 quarters · filed 2026-02-25 | $397.00M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-03-31 | $4.70M 10-Q · filed 2025-04-30 | $101.30M derived: sum of 2 quarters · filed 2026-02-25 | $189.70M derived: sum of 3 quarters · filed 2026-02-25 | $337.20M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2023-12-31 | $96.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $185.00M derived: sum of 2 quarters · filed 2026-02-25 | $332.50M derived: sum of 3 quarters · filed 2026-02-25 | $332.50M 10-K · filed 2026-02-25 | ||||
| 2023-09-30 | $88.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $235.90M derived: sum of 2 quarters · filed 2024-10-30 | $235.90M 10-Q · filed 2024-10-30 | $322.50M derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2023-06-30 | $147.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $147.50M 10-Q · filed 2024-07-31 | $234.10M derived: sum of 3 quarters · filed 2025-02-26 | $285.10M derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-01 | $86.60M derived: sum of 2 quarters · filed 2025-02-26 | $137.60M derived: sum of 3 quarters · filed 2025-02-26 | $275.30M derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2022-12-31 | $86.60M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $137.60M derived: sum of 2 quarters · filed 2025-02-26 | $275.30M derived: sum of 3 quarters · filed 2025-02-26 | $275.70M 10-K · filed 2025-02-26 | ||||
| 2022-09-30 | $51.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $188.70M derived: sum of 2 quarters · filed 2023-11-01 | $189.10M 10-Q · filed 2023-11-01 | $212.30M derived: sum of 4 quarters · filed 2024-02-21 | ||||
| 2022-06-30 | $137.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $138.10M 10-Q · filed 2023-08-02 | $161.30M derived: sum of 3 quarters · filed 2024-02-21 | $206.00M derived: sum of 4 quarters · filed 2024-02-21 | ||||
| 2022-03-31 | $400.00K 10-Q · filed 2023-05-03 | $23.60M derived: sum of 2 quarters · filed 2024-02-21 | $68.30M derived: sum of 3 quarters · filed 2024-02-21 | $155.30M derived: sum of 4 quarters · filed 2024-02-21 | ||||
| 2021-12-31 | $23.20M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $67.90M derived: sum of 2 quarters · filed 2024-02-21 | $154.90M derived: sum of 3 quarters · filed 2024-02-21 | $153.30M 10-K · filed 2024-02-21 | ||||
| 2021-09-30 | $44.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $131.70M derived: sum of 2 quarters · filed 2022-11-02 | $130.10M 10-Q · filed 2022-11-02 | $160.60M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-06-30 | $87.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $85.40M 10-Q · filed 2022-08-03 | $115.90M derived: sum of 3 quarters · filed 2023-02-22 | $134.20M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-03-31 | -$1.60M 10-Q · filed 2022-05-04 | $28.90M derived: sum of 2 quarters · filed 2023-02-22 | $47.20M derived: sum of 3 quarters · filed 2023-02-22 | $99.90M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2020-12-31 | $30.50M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $48.80M derived: sum of 2 quarters · filed 2023-02-22 | $101.50M derived: sum of 3 quarters · filed 2023-02-22 | $92.80M 10-K · filed 2023-02-22 | ||||
| 2020-09-30 | $18.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $71.00M derived: sum of 2 quarters · filed 2021-11-03 | $62.30M 10-Q · filed 2021-11-03 | $88.10M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-06-30 | $52.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $44.00M 10-Q · filed 2021-08-04 | $69.80M derived: sum of 3 quarters · filed 2022-02-24 | $101.50M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-03-31 | -$8.70M 10-Q · filed 2020-04-29 | $17.10M derived: sum of 2 quarters · filed 2022-02-24 | $48.80M derived: sum of 3 quarters · filed 2022-02-24 | $110.60M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2019-12-31 | $25.80M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $57.50M derived: sum of 2 quarters · filed 2022-02-24 | $119.30M derived: sum of 3 quarters · filed 2022-02-24 | $120.20M 10-K · filed 2022-02-24 | ||||
| 2019-09-30 | $31.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-28 | $93.50M derived: sum of 2 quarters · filed 2020-10-28 | $94.40M 10-Q · filed 2020-10-28 | $145.00M derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2019-06-30 | $61.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | $62.70M 10-Q · filed 2020-07-29 | $113.30M derived: sum of 3 quarters · filed 2021-02-24 | $133.90M derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2019-03-31 | $900.00K 10-Q · filed 2020-04-29 | $51.50M derived: sum of 2 quarters · filed 2021-02-24 | $72.10M derived: sum of 3 quarters · filed 2021-02-24 | $103.40M derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2018-12-31 | $50.60M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $71.20M derived: sum of 2 quarters · filed 2021-02-24 | $102.50M derived: sum of 3 quarters · filed 2021-02-24 | $102.70M 10-K · filed 2021-02-24 | ||||
| 2018-09-30 | $20.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $51.90M derived: sum of 2 quarters · filed 2019-10-30 | $52.10M 10-Q · filed 2019-10-30 | $148.40M derived: sum of 4 quarters · filed 2020-02-26 | ||||
| 2018-06-30 | $31.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | $31.50M 10-Q · filed 2019-07-31 | $127.80M derived: sum of 3 quarters · filed 2020-02-26 | $220.50M derived: sum of 4 quarters · filed 2020-02-26 | ||||
| 2018-03-31 | $200.00K 10-Q · filed 2019-05-01 | $96.50M derived: sum of 2 quarters · filed 2020-02-26 | $189.20M derived: sum of 3 quarters · filed 2020-02-26 | |||||
| 2017-12-31 | $96.30M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $189.00M derived: sum of 2 quarters · filed 2020-02-26 | $346.90M 10-K · filed 2020-02-26 | |||||
| 2017-09-30 | $92.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | $250.60M 10-Q · filed 2018-10-31 | ||||||
| 2017-06-30 | $157.90M 10-Q · filed 2018-08-01 | |||||||
| 2016-12-31 | $78.70M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $140.40M derived: sum of 2 quarters · filed 2019-02-27 | $273.80M derived: sum of 3 quarters · filed 2019-02-27 | $362.40M 10-K · filed 2019-02-27 | ||||
| 2016-09-30 | $61.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-25 | $195.10M derived: sum of 2 quarters · filed 2017-10-25 | $283.70M 10-Q · filed 2017-10-25 | $460.10M derived: sum of 4 quarters · filed 2018-02-21 | ||||
| 2016-06-30 | $133.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-27 | $222.00M 10-Q · filed 2017-07-27 | $398.40M derived: sum of 3 quarters · filed 2018-02-21 | $405.20M derived: sum of 4 quarters · filed 2018-02-21 | ||||
| 2016-03-31 | $88.60M 10-Q · filed 2017-04-26 | $265.00M derived: sum of 2 quarters · filed 2018-02-21 | $271.80M derived: sum of 3 quarters · filed 2018-02-21 | $365.70M derived: sum of 4 quarters · filed 2018-02-21 | ||||
| 2015-12-31 | $176.40M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21 | $183.20M derived: sum of 2 quarters · filed 2018-02-21 | $277.10M derived: sum of 3 quarters · filed 2018-02-21 | $293.30M 10-K · filed 2018-02-21 | $293.33M 10-K · filed 2016-02-25 | |||
| 2015-09-30 | $6.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-27 | $100.70M derived: sum of 2 quarters · filed 2016-10-27 | $116.90M 10-Q · filed 2016-10-27 | $116.91M 10-Q · filed 2015-10-27 | $134.82M derived: sum of 4 quarters · filed 2017-02-22 | |||
| 2015-06-30 | $93.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-28 | $110.10M 10-Q · filed 2016-07-28 | $110.09M 10-Q · filed 2015-07-28 | $128.02M derived: sum of 3 quarters · filed 2017-02-22 | $165.33M derived: sum of 4 quarters · filed 2017-02-22 | |||
| 2015-03-31 | $16.20M 10-Q · filed 2016-04-28 | $16.17M 10-Q · filed 2015-04-28 | $34.12M derived: sum of 2 quarters · filed 2017-02-22 | $71.43M derived: sum of 3 quarters · filed 2017-02-22 | $145.00M derived: sum of 4 quarters · filed 2017-02-22 | |||
| 2014-12-31 | $17.92M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-22 | $55.23M derived: sum of 2 quarters · filed 2017-02-22 | $128.80M derived: sum of 3 quarters · filed 2017-02-22 | $195.60M 10-K · filed 2017-02-22 | $195.56M 10-K · filed 2015-02-24 | |||
| 2014-09-30 | $37.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-27 | $110.88M derived: sum of 2 quarters · filed 2015-10-27 | $177.68M 10-Q · filed 2015-10-27 | $200.19M derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2014-06-30 | $73.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-28 | $140.37M 10-Q · filed 2015-07-28 | $162.87M derived: sum of 3 quarters · filed 2016-02-25 | $196.86M derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2014-03-31 | $66.80M 10-Q · filed 2015-04-28 | $89.31M derived: sum of 2 quarters · filed 2016-02-25 | $123.29M derived: sum of 3 quarters · filed 2016-02-25 | $163.99M derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2013-12-31 | $22.51M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $56.49M derived: sum of 2 quarters · filed 2016-02-25 | $97.19M derived: sum of 3 quarters · filed 2016-02-25 | $142.14M 10-K · filed 2016-02-25 | ||||
| 2013-09-30 | $33.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-28 | $74.68M derived: sum of 2 quarters · filed 2014-10-28 | $119.63M 10-Q · filed 2014-10-28 | $146.09M derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2013-06-30 | $40.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-29 | $85.65M 10-Q · filed 2014-07-29 | $112.11M derived: sum of 3 quarters · filed 2015-02-24 | $130.84M derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2013-03-31 | $44.95M 10-Q · filed 2014-04-29 | $71.41M derived: sum of 2 quarters · filed 2015-02-24 | $90.14M derived: sum of 3 quarters · filed 2015-02-24 | $117.78M derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2012-12-31 | $26.46M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $45.20M derived: sum of 2 quarters · filed 2015-02-24 | $72.83M derived: sum of 3 quarters · filed 2015-02-24 | $101.50M 10-K · filed 2015-02-24 | ||||
| 2012-09-30 | $18.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-29 | $46.37M derived: sum of 2 quarters · filed 2013-10-29 | $75.05M 10-Q · filed 2013-10-29 | $96.51M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-06-30 | $27.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-25 | $56.31M 10-Q · filed 2013-07-25 | $77.77M derived: sum of 3 quarters · filed 2014-02-25 | $88.76M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-03-31 | $28.68M 10-Q · filed 2013-04-25 | $50.14M derived: sum of 2 quarters · filed 2014-02-25 | $61.13M derived: sum of 3 quarters · filed 2014-02-25 | $69.99M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2011-12-31 | $21.46M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $32.45M derived: sum of 2 quarters · filed 2014-02-25 | $41.32M derived: sum of 3 quarters · filed 2014-02-25 | $46.51M 10-K · filed 2014-02-25 | $46.94M 10-K · filed 2012-02-28 | |||
| 2011-09-30 | $10.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01 | $19.86M derived: sum of 2 quarters · filed 2012-11-01 | $25.05M 10-Q · filed 2012-11-01 | $45.40M derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2011-06-30 | $8.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-26 | $14.06M 10-Q · filed 2012-07-26 | $34.40M derived: sum of 3 quarters · filed 2013-02-26 | $34.56M derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2011-03-31 | $5.19M 10-Q · filed 2012-04-26 | $25.54M derived: sum of 2 quarters · filed 2013-02-26 | $25.70M derived: sum of 3 quarters · filed 2013-02-26 | $27.00M derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2010-12-31 | $20.35M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $20.50M derived: sum of 2 quarters · filed 2013-02-26 | $21.81M derived: sum of 3 quarters · filed 2013-02-26 | $22.68M 10-K · filed 2013-02-26 | ||||
| 2010-09-30 | $156.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-27 | $1.46M derived: sum of 2 quarters · filed 2011-10-27 | $2.33M 10-Q · filed 2011-10-27 | $14.96M derived: sum of 4 quarters · filed 2012-02-28 | ||||
| 2010-06-30 | $1.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-28 | $2.18M 10-Q · filed 2011-07-28 | $14.81M derived: sum of 3 quarters · filed 2012-02-28 | $23.19M derived: sum of 4 quarters · filed 2012-02-28 | ||||
| 2010-03-31 | $876.00K 10-Q · filed 2011-04-28 | $13.50M derived: sum of 2 quarters · filed 2012-02-28 | $21.89M derived: sum of 3 quarters · filed 2012-02-28 | |||||
| 2009-12-31 | $12.63M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $21.01M derived: sum of 2 quarters · filed 2012-02-28 | $23.93M 10-K · filed 2012-02-28 | |||||
| 2009-09-30 | $8.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-28 | $11.30M 10-Q · filed 2010-10-28 | ||||||
| 2009-06-30 | $2.92M 10-Q · filed 2010-07-28 | |||||||
| 2008-12-31 | $1.63M 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |